Sutro Biopharma, Inc. SEC filings STRO
Sutro Biopharma, Inc. has 624 filings in SEC EDGAR's recent list, going back to Nov 8, 2006. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Apr 1, 2026 | — |
| CORRESP | Letter to the SEC | Mar 30, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 27, 2026 | — |
| EFFECT | Filing | Nov 21, 2023 | — |
| CORRESP | Letter to the SEC | Nov 17, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2023 | — |
| EFFECT | Filing | May 19, 2022 | — |
| POS EX | Filing | May 18, 2022 | — |
| POSASR | Filing | Feb 28, 2022 | — |
| EFFECT | Filing | Oct 11, 2019 | — |
| CORRESP | Letter to the SEC | Oct 9, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 8, 2019 | — |
| CT ORDER | Filing | Sep 27, 2018 | — |
| EFFECT | Filing | Sep 26, 2018 | — |
| CORRESP | Letter to the SEC | Sep 24, 2018 | — |
| CORRESP | Letter to the SEC | Sep 24, 2018 | — |
| CERT | Filing | Sep 21, 2018 | — |
| 8-A12B | Filing | Sep 18, 2018 | — |
| CORRESP | Letter to the SEC | Sep 17, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2018 | — |
| CORRESP | Letter to the SEC | Sep 10, 2018 | — |
| CORRESP | Letter to the SEC | Aug 29, 2018 | — |
| UPLOAD | Letter from the SEC | Aug 24, 2018 | — |
| DRSLTR | Filing | Aug 20, 2018 | — |
| DRSLTR | Filing | Aug 8, 2018 | — |
| D/A | Filing | Aug 8, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 30, 2018 | — |
| DRSLTR | Filing | Jul 10, 2018 | — |
| DRS/A | Filing | Jul 10, 2018 | — |
| UPLOAD | Letter from the SEC | Jun 29, 2018 | — |
| D | Filing | Jun 6, 2018 | — |
| DRS | Filing | Jun 1, 2018 | — |
| REGDEX/A | Auto-generated paper document | Mar 11, 2009 | — |
| REGDEX | Auto-generated paper document | Oct 24, 2007 | — |
| REGDEX/A | Auto-generated paper document | Apr 23, 2007 | — |
| REGDEX | Auto-generated paper document | Dec 29, 2006 | — |
| REGDEX | Auto-generated paper document | Nov 8, 2006 | — |
Showing 37 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- STRO (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1382101
- Former names
- SUTRO BIOPHARMA INC (until Nov 8, 2018); Fundamental Applied Biology Inc (until Oct 24, 2007)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.